NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
PharmaBlock Sciences (Nanjing) Inc (SHE: 300725)
300725 Technical Analysis
2
As on 11th Mar 2025 300725 STOCK Price closed @ 38.83 and we RECOMMEND Buy for LONG-TERM with Stoploss of 35.75 & Strong Sell for SHORT-TERM with Stoploss of 44.67 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300725STOCK Price
Open | 38.51 | Change | Price | % |
High | 39.21 | 1 Day | -0.74 | -1.87 |
Low | 38.30 | 1 Week | 0.52 | 1.36 |
Close | 38.83 | 1 Month | 7.76 | 24.98 |
Volume | 7073280 | 1 Year | -4.68 | -10.76 |
52 Week High 48.81 | 52 Week Low 24.40 |
SHE China Most Active Stocks
002195 | 6.97 | 9.94% |
002426 | 3.87 | 7.20% |
002131 | 4.31 | 1.17% |
300296 | 8.05 | 11.34% |
300451 | 7.65 | -4.73% |
300083 | 11.02 | 8.04% |
000592 | 3.18 | 10.03% |
000903 | 4.46 | 10.12% |
002122 | 5.41 | 4.44% |
000564 | 2.96 | 0.00% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300725 Daily Charts |
300725 Intraday Charts |
Whats New @ Bazaartrend |
300725 Free Analysis |
|
300725 Important Levels Intraday
RESISTANCE | 40.58 |
RESISTANCE | 40.02 |
RESISTANCE | 39.67 |
RESISTANCE | 39.33 |
SUPPORT | 38.33 |
SUPPORT | 37.99 |
SUPPORT | 37.64 |
SUPPORT | 37.08 |
300725 Forecast March 2025
4th UP Forecast | 57.93 |
3rd UP Forecast | 51.8 |
2nd UP Forecast | 48.02 |
1st UP Forecast | 44.23 |
1st DOWN Forecast | 33.43 |
2nd DOWN Forecast | 29.64 |
3rd DOWN Forecast | 25.86 |
4th DOWN Forecast | 19.73 |
300725 Weekly Forecast
4th UP Forecast | 43.36 |
3rd UP Forecast | 41.91 |
2nd UP Forecast | 41.01 |
1st UP Forecast | 40.11 |
1st DOWN Forecast | 37.55 |
2nd DOWN Forecast | 36.65 |
3rd DOWN Forecast | 35.75 |
4th DOWN Forecast | 34.30 |
300725 Forecast2025
4th UP Forecast | 91.34 |
3rd UP Forecast | 74.5 |
2nd UP Forecast | 64.09 |
1st UP Forecast | 53.68 |
1st DOWN Forecast | 23.98 |
2nd DOWN Forecast | 13.57 |
3rd DOWN Forecast | 3.16 |
4th DOWN Forecast | -13.68 |
PharmaBlock Sciences (Nanjing) Inc ( SHE China Symbol : 300725 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300725 Other Details
Segment | EQ | |
Market Capital | 30066831360.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
300725 Address
![]() |
300725 Latest News
300725 Business Profile
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China. Address: 10 Xuefu Road, Nanjing, China, 210032
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service